Hill-Rom Holdings Inc (HRC) Position Reduced by Gareth Morgan Investments Limited Partnership

Gareth Morgan Investments Limited Partnership trimmed its holdings in Hill-Rom Holdings Inc (NYSE:HRC) by 24.4% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 12,127 shares of the medical technology company’s stock after selling 3,919 shares during the quarter. Gareth Morgan Investments Limited Partnership’s holdings in Hill-Rom Holdings were worth $965,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of HRC. Independent Portfolio Consultants Inc. boosted its position in shares of Hill-Rom Holdings by 171.5% in the second quarter. Independent Portfolio Consultants Inc. now owns 1,344 shares of the medical technology company’s stock valued at $107,000 after acquiring an additional 849 shares during the period. Meadow Creek Investment Management LLC lifted its position in Hill-Rom Holdings by 3.9% in the first quarter. Meadow Creek Investment Management LLC now owns 1,696 shares of the medical technology company’s stock worth $120,000 after purchasing an additional 64 shares during the period. Neuburgh Advisers LLC lifted its position in Hill-Rom Holdings by 3.9% in the first quarter. Neuburgh Advisers LLC now owns 2,332 shares of the medical technology company’s stock worth $165,000 after purchasing an additional 88 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Hill-Rom Holdings by 10.2% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,201 shares of the medical technology company’s stock worth $175,000 after purchasing an additional 204 shares during the period. Finally, Tyers Asset Management LLC lifted its position in Hill-Rom Holdings by 3.9% in the first quarter. Tyers Asset Management LLC now owns 2,968 shares of the medical technology company’s stock worth $210,000 after purchasing an additional 112 shares during the period. 82.31% of the stock is owned by institutional investors.

Shares of Hill-Rom Holdings Inc (NYSE:HRC) opened at 73.60 on Friday. The firm has a market capitalization of $4.85 billion, a price-to-earnings ratio of 42.89 and a beta of 1.21. Hill-Rom Holdings Inc has a 52 week low of $50.50 and a 52 week high of $84.65. The stock has a 50 day moving average price of $75.26 and a 200-day moving average price of $75.35.

Hill-Rom Holdings (NYSE:HRC) last announced its quarterly earnings data on Friday, July 28th. The medical technology company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. The business had revenue of $689.10 million during the quarter, compared to the consensus estimate of $695.50 million. Hill-Rom Holdings had a return on equity of 19.99% and a net margin of 4.27%. Hill-Rom Holdings’s revenue for the quarter was up 5.1% on a year-over-year basis. During the same period in the prior year, the company earned $0.81 EPS. On average, equities research analysts forecast that Hill-Rom Holdings Inc will post $3.82 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, September 29th. Shareholders of record on Friday, September 15th will be given a $0.18 dividend. The ex-dividend date is Thursday, September 14th. This represents a $0.72 annualized dividend and a yield of 0.98%. Hill-Rom Holdings’s dividend payout ratio is presently 41.62%.

HRC has been the subject of several research reports. Zacks Investment Research raised Hill-Rom Holdings from a “hold” rating to a “buy” rating and set a $86.00 target price for the company in a research report on Friday, May 26th. ValuEngine raised Hill-Rom Holdings from a “hold” rating to a “buy” rating in a research report on Friday, June 2nd. Barclays PLC raised their target price on Hill-Rom Holdings from $80.00 to $86.00 and gave the stock an “overweight” rating in a research report on Friday, June 9th. Cantor Fitzgerald began coverage on Hill-Rom Holdings in a report on Thursday, June 29th. They set a “neutral” rating and a $86.00 price objective for the company. Finally, Needham & Company LLC began coverage on Hill-Rom Holdings in a report on Thursday, June 29th. They set a “buy” rating and a $95.00 price objective for the company. Three equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $88.17.

COPYRIGHT VIOLATION WARNING: This article was first reported by BBNS and is owned by of BBNS. If you are accessing this article on another site, it was stolen and reposted in violation of US & international copyright & trademark law. The legal version of this article can be viewed at https://baseballnewssource.com/markets/gareth-morgan-investments-limited-partnership-has-965000-position-in-hill-rom-holdings-inc-hrc/1602282.html.

In other news, SVP Andreas G. Frank sold 6,870 shares of the stock in a transaction dated Thursday, September 14th. The stock was sold at an average price of $77.48, for a total value of $532,287.60. Following the completion of the sale, the senior vice president now owns 16,701 shares of the company’s stock, valued at $1,293,993.48. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Andreas G. Frank sold 3,940 shares of the firm’s stock in a transaction that occurred on Wednesday, September 13th. The stock was sold at an average price of $77.84, for a total value of $306,689.60. Following the sale, the senior vice president now directly owns 16,701 shares of the company’s stock, valued at approximately $1,300,005.84. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by company insiders.

Hill-Rom Holdings Company Profile

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Institutional Ownership by Quarter for Hill-Rom Holdings (NYSE:HRC)

Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with our FREE daily email newsletter.

 


Latest News

American League Once Again Dominates National League
American League Once Again Dominates National League
Los Angeles Dodgers Waiting But Magic Number Down to One
Los Angeles Dodgers Waiting But Magic Number Down to One
Young Girl Hit by Foul Ball Rushed to Hospital
Young Girl Hit by Foul Ball Rushed to Hospital
New Home Run Record Reached in Major League Baseball
New Home Run Record Reached in Major League Baseball
Will 2017 MLB Season End with No 20-Game Winner?
Will 2017 MLB Season End with No 20-Game Winner?
Cleveland Indians Winning Streak Snapped at 22
Cleveland Indians Winning Streak Snapped at 22


Leave a Reply

 
© 2006-2017 BBNS.